Neffy (epinephrine)
- Region
- 🇪🇺 EU
- Active substance
- epinephrine
- Company
- Ars Pharmaceuticals Irl Limited
- Status
- Application withdrawn
- Therapeutic area
- Hypersensitivity; Anaphylaxis
- Application
- EMEA/H/C/005584
- ATC
- C01CA24
- Official record
- www.ema.europa.eu
Indication
Emergency treatment of allergic reactions, including anaphylaxis.
Regulatory milestones
No milestones recorded in the last year.
Same substance in other markets
- 🇪🇺 Eurneffy Authorised · ALK-Abelló A/S
- 🇺🇸 Flavalta Approved · Deproco
- 🇺🇸 Epinephrine Approved · Baxter Hlthcare Corp
Follow Neffy
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.